Perinatal transmission and cure of extensively drug-resistant tuberculosis in an infant

V Singh; R Perumal; M Wessels; F Hai; K Lutchminarain; K Naidoo; K Swe Swe-Han

doi:10.7196/AJTCCM.2025.v31i2.2346

PDF HTML

Published: 2025-06-04

DOI: https://doi.org/10.7196/AJTCCM.2025.v31i2.2346

Keywords:

Extensively Drug-Resistant Tuberculosis, Perinatal tuberculosis

V Singh

Department of Medical Microbiology, Albert Luthuli Laboratory, National Health Laboratory Service, Durban, South Africa; Department of Medical Microbiology, School of Laboratory Medicine and Medical Science, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa

https://orcid.org/0009-0001-1292-760X

R Perumal

Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa; South African Medical Research Council-Centre for the AIDS Programme of Research in South Africa (CAPRISA) HIV-TB Pathogenesis and Treatment Research Unit, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa; Department of Pulmonology and Critical Care, Division of Internal Medicine, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa

https://orcid.org/0000-0001-8892-2904

M Wessels

Queen Nandi Regional Hospital, KwaZulu-Natal Provincial Department of Health, South Africa

https://orcid.org/0009-0004-8191-1486

F Hai

King Dinuzulu Hospital Complex, KwaZulu-Natal Provincial Department of Health, South Africa

https://orcid.org/0009-0002-5190-7780

K Lutchminarain

https://orcid.org/0000-0002-0839-3369

K Naidoo

https://orcid.org/0000-0002-8874-6661

K Swe Swe-Han

https://orcid.org/0000-0002-4574-6258

Abstract

We describe a rare case of perinatally acquired extensively drug-resistant tuberculosis in an infant. The infant was successfully treated with an individualised all-oral multidrug regimen containing delamanid, a drug rarely described in the treatment of perinatal tuberculosis.

Downloads

Download data is not yet available.

Issue

AJTCCM Vol. 31 No. 2

Section

Original Research: Brief Reports

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors retain copyright and grant the journal right of first publication.

How to Cite

Singh V, Perumal R, Wessels M, Hai F, Lutchminarain K, Naidoo K, et al. Perinatal transmission and cure of extensively drug-resistant tuberculosis in an infant. Afr J Thoracic Crit Care Med [Internet]. 2025 Jun. 4 [cited 2026 Apr. 25];31(2):e2346. Available from: https://www.samajournals.co.za/index.php/ajtccm/article/view/2346

References

1. World Health Organization. Global tuberculosis report 2023. Geneva: WHO, 2023.

https://www.who.int/teams/global-programme-on-tuberculosis-and-lung-health/tb-

reports/global-tuberculosis-report-2023 (accessed 10 June 2024).

2. World Health Organization. Meeting report of the WHO expert consultation on the definition of extensively drug-resistant tuberculosis. 27-29 October 2020. Geneva: WHO, 2020. https://www.who.int/publications/i/item/9789240018662 (accessed

10 June 2024).

3. Shenoi A, Kavitha A. Perinatal tuberculosis. Pediatr Infect Dis 2019;1(1):30-33.

https://doi.org/10.5005/jp-journals-10081-1107

4. Singh M, Kothur K, Dayal D, Kusuma S. Perinatal tuberculosis: A case series. J Trop Pediatr 2007;53(2):135-138. https://doi.org/10.1093/tropej/fml074

5. Cantwell MF, Shehab ZM, Costello AM, et al. Brief report: Congenital tuberculosis. N Engl J Med 1994;330(15):1051-1054. https://doi.org/10.1056/ NEJM199404143301505

6. WorldHealthOrganization.WHOconsolidatedguidelinesontuberculosis.Module5: Management of tuberculosis in children and adolescents. Geneva: WHO, 2022. https://www.who.int/publications/i/item/9789240046764 (accessed 12 June 2024).

7. National Department of Health, South Africa. Clinical management of rifampicin- resistant tuberculosis: Updated clinical reference guide. Pretoria: NDoH, 2023. https:// knowledgehub.health.gov.za/elibrary/clinical-management-rifampicin-resistant- tubercolosis (accessed 12 June 2024).

8. World Health Organization. WHO consolidated guidelines on tuberculosis. Module 1: Prevention – tuberculosis preventive treatment. Geneva: WHO, 2024. https://www. who.int/publications/i/item/9789240096196 (accessed 13 September 2024).

9. Boast A, How JA, Lau C, et al. Pre-extensively drug-resistant congenital tuberculosis in an extremely premature baby. Clin Infect Dis 2024;78(1):149-153. https://doi. org/10.1093/cid/ciad540

10. Espiritu N, Aguirre L, Jave O, Sanchez L, Kirwan DE, Gilman RH. Congenital transmission of multidrug-resistant tuberculosis. Am J Trop Med Hyg 2014;91(1):92-95. https://doi.org/10.4269/ajtmh.13-0002

Most read articles by the same author(s)

Make a Submission

Scopus 2023 CiteScore: 1.5

CiteScore measures average citations received per document published in the serial.

Announcements

Submission guidelines

First time authors, please follow the guidelines above on how to submit the manuscript on the AJTCCM submission portal.

For guidelines on general manuscript preparation, please click here: General formatting guidelines

For information on how to prepare specific article types, please refer to the relevant section under the drop-down Author Guidelines menu.

AJTCCM News

Accreditation

The African Journal of Thoracic and Critical Care Medicine is now SA DoHET-accredited, Scopus-indexed and indexed with NCBI databases including PubMed Central.

Editorial board

Editor-in-chief

Prof K Dheda, MB BCh (Wits), FCP(SA), FCCP, PhD (Lond), FRCP (Lond). Head Department the Division of Pulmonology, Department of Medicine, University of Cape Town, Cape Town, South Africa; Professor of Mycobacteriology and Global Health, London School of Hygiene and Tropical Medicine, London, United Kingdom; Director, Centre for Lung Infection and Immunity, University of Cape Town Lung Institute, South Africa.

Deputy Editor

Prof C Koegelenberg, MB ChB, MMed (Int), FCP (SA), MRCP (UK), Cert Pulm (SA), PhD. Senior Specialist: Pulmonology & General Medicine, University of Stellenbosch & Tygerberg Academic Hospital, South Africa.

Section Editor: Breath-taking News

Prof E M Irusen, MB ChB, FCP(SA), PhD. Head: Division of Pulmonology Department of Medicine Faculty of Health Sciences University of Stellenbosch & Tygerberg Academic Hospital, South Africa.

President SA Thoracic Society

Prof. R Masekela, MB BCh, MMed (Paeds)Pret, Dipl Allerg (SA), PhD, FCCP. Adjunct Professor, Department of Paediatrics and Child Health, Nelson R Mandela School of Medicine, South Africa.
Expertise: Paediatrics, asthma, chronic lung disease, epidemiology

Article Sidebar

Main Article Content